Transaction · 0000950170-25-015693

Crystal Adam

Crystal Adam, SR, reported an open-market or private sale at Tango Therapeutics, Inc. involving 6851.000000 shares for an estimated $21658.75. Reported holdings after the transaction were 158210.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SSR
TNGXTango Therapeutics, Inc.
Filing timeFeb 07
Trade dateFeb 05, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

TNGX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TNGX since 2025-02-07Filed 573 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000950170-25-015693
Common Stock
Transaction date
Feb 05, 2025
Filed Feb 07, 2025, 01:08 AM · 2d delay
Shares
6.85k sh
$316 per share
Estimated value
-$2.16M
Computed from shares × price
Holdings after
158k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold…

  2. F2

    Represents the weighted average sales price per share. The shares sold at prices ranging from $2.86 to $3.07 per share. Full information regarding the number of shares sold at each price shall be prov…

  3. F3

    Represents the weighted average sales price per share. The shares sold at prices ranging from $3.00 to $3.245 per share. Full information regarding the number of shares sold at each price shall be pr…

Original filing · 0000950170-25-015693
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TNGX